AVEO
Barclays’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-34,444
| Closed | -$515K | – | 4637 |
|
|
2022
Q4 | $515K | Buy |
34,444
+26,622
| +340% | +$398K | ﹤0.01% | 2583 |
|
|
2022
Q3 | $65K | Buy |
7,822
+2,044
| +35% | +$17K | ﹤0.01% | 3575 |
|
|
2022
Q2 | $38K | Sell |
5,778
-243
| -4% | -$1.6K | ﹤0.01% | 3844 |
|
|
2022
Q1 | $34K | Buy |
+6,021
| New | +$34K | ﹤0.01% | 4157 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4099 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4471 |
|
|
2019
Q3 | – | Sell |
-222,356
| Closed | -$150K | – | 4615 |
|
|
2019
Q2 | $150K | Buy |
222,356
+192,067
| +634% | +$130K | ﹤0.01% | 3366 |
|
|
2019
Q1 | $25K | Buy |
+30,289
| New | +$25K | ﹤0.01% | 3866 |
|
|
2018
Q4 | – | Sell |
-38,942
| Closed | -$129K | – | 4605 |
|
|
2018
Q3 | $129K | Buy |
38,942
+31,483
| +422% | +$104K | ﹤0.01% | 3288 |
|
|
2018
Q2 | $17K | Sell |
7,459
-280,043
| -97% | -$638K | ﹤0.01% | 3717 |
|
|
2018
Q1 | $834K | Sell |
287,502
-17,979
| -6% | -$52.2K | ﹤0.01% | 1945 |
|
|
2017
Q4 | $852K | Sell |
305,481
-14,419
| -5% | -$40.2K | ﹤0.01% | 1728 |
|
|
2017
Q3 | $1.17M | Buy |
+319,900
| New | +$1.17M | ﹤0.01% | 1494 |
|
|
2014
Q4 | – | Sell |
-52
| Closed | – | – | 4420 |
|
|
2014
Q3 | $0 | Sell |
52
-86,273
| -100% | – | ﹤0.01% | 4496 |
|
|
2014
Q2 | $86K | Buy |
86,325
+84,130
| +3,833% | +$83.8K | ﹤0.01% | 2796 |
|
|
2014
Q1 | $2K | Buy |
2,195
+886
| +68% | +$807 | ﹤0.01% | 4164 |
|
|
2013
Q4 | $1K | Buy |
1,309
+792
| +153% | +$605 | ﹤0.01% | 4280 |
|
|
2013
Q3 | $1K | Sell |
517
-9,198
| -95% | -$17.8K | ﹤0.01% | 4084 |
|
|
2013
Q2 | $25K | Buy |
+9,715
| New | +$25K | ﹤0.01% | 3611 |
|